Back
AtkinsRéalis Group, Inc. Vs. AnaptysBio, Inc. Industry Stock Comparison
Buy
68
ATRL.TO
AtkinsRéalis Group, Inc.
Last Price:
$95.46
Seasonality Move:
6.96%
Buy
60
ANAB
AnaptysBio, Inc.
Last Price:
$62.30
Seasonality Move:
-7.42%
Buy
68
AtkinsRéalis Group, Inc. (ATRL.TO)
is a Buy
Is AtkinsRéalis Group, Inc. a Buy, Sell or Hold?
-
The current AtkinsRéalis Group, Inc. [ATRL.TO] share price is $95.46. The Score for ATRL.TO is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
-
ATRL.TO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
60
AnaptysBio, Inc. (ANAB)
is a Buy
Is AnaptysBio, Inc. a Buy, Sell or Hold?
-
The current AnaptysBio, Inc. [ANAB] share price is $60.55. The Score for ANAB is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
ANAB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ATRL.TO Stock Price Chart
What is AtkinsRéalis Group, Inc.'s stock price today?
-
The AtkinsRéalis Group, Inc. share price today is $95.46The current trend is moderately bearish and ATRL.TO is experiencing slight selling pressure.
ANAB Stock Price Chart
What is AnaptysBio, Inc.'s stock price today?
-
The AnaptysBio, Inc. share price today is $60.55Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ANAB is experiencing slight buying pressure.
ATRL.TO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.27 | Sell |
| Relative Strength Index (14 RSI): | 49.02 | Sell |
| Chaikin Money Flow: | -168244 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (92.87 - 102.09) | Sell |
| Bollinger Bands (100): | (88.3 - 98.78) | Buy |
ANAB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.1 | Buy |
| Relative Strength Index (14 RSI): | 68.42 | Buy |
| Chaikin Money Flow: | 554241 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.33 - 55.97) | Buy |
| Bollinger Bands (100): | (36.31 - 51.31) | Buy |
ATRL.TO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 94.93 | Buy |
| 20-day SMA: | 97.15 | Sell |
| 50-day SMA: | 95.32 | Buy |
| 200-day SMA: | 94.84 | Buy |
| 8-day EMA: | 95.57 | Sell |
| 20-day EMA: | 95.98 | Sell |
| 50-day EMA: | 95.32 | Buy |
| 200-day EMA: | 90.9 | Buy |
ANAB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 55.53 | Buy |
| 20-day SMA: | 53.59 | Buy |
| 50-day SMA: | 50.03 | Buy |
| 200-day SMA: | 33.42 | Buy |
| 8-day EMA: | 55.76 | Buy |
| 20-day EMA: | 53.82 | Buy |
| 50-day EMA: | 49.9 | Buy |
| 200-day EMA: | 37.22 | Buy |
AtkinsRéalis Group, Inc. Earnings Growth & ATRL.TO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.54 per share, and an increase next year of $0.83 per share.
AnaptysBio, Inc. Earnings Growth & ANAB Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.83 per share, a decrease next quarter of $0.24 per share, a decrease this year of $2.54 per share, and a decrease next year of $0.55 per share.
AtkinsRéalis Group, Inc. Technical Analysis
| Feb 19 | Feb 20 | Feb 23 | Feb 24 | Feb 25 | Feb 26 | Feb 27 | Mar 2 | Mar 3 | Mar 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | Mar | |||||||||
| 19 | 20 | 23 | 24 | 25 | 26 | 27 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
AnaptysBio, Inc. Technical Analysis
| Feb 19 | Feb 20 | Feb 23 | Feb 24 | Feb 25 | Feb 26 | Feb 27 | Mar 2 | Mar 3 | Mar 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | Mar | |||||||||
| 19 | 20 | 23 | 24 | 25 | 26 | 27 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||